ATC Group: A06AA02 Docusate sodium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AA02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A06 Laxatives
3 A06A Laxatives
4 A06AA Softeners, emollients
5 A06AA02 Docusate sodium

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.15 g

Active ingredients in A06AA02

Active Ingredient Description

Docusate is an anionic wetting agent, which acts as a faecal softener by lowering the surface tension and allowing penetration of accumulated hard dry faeces by water and salts. Docusate sodium also possesses stimulant activity.

Related product monographs

Title Information Source Document Type  
DULCOEASE Capsule, soft Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
WAXSOL Ear drops Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

France (FR)

Hong Kong (HK)

Ireland (IE)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Poland (PL)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.